MCHP vs RGEN · rev $4.71B vs P/E 143, rev $204.1M
Microchip Technology Inc (MCHP) versus Repligen Corporation (RGEN) — a side-by-side from cached financials, not a winner call.
Microchip Technology Inc (MCHP) is a semiconductors company listed on US.
Repligen Corporation (RGEN) is a medical instruments & supplies company listed on NASDAQ.
Latest reported MCHP revenue for 2026-03-31 was $4.71B. Net income was $230.0M. Revenue was up 7.1% from 2025-03-31 to 2026-03-31. MCHP currently screens at market cap $39.41B.
Latest reported RGEN revenue for 2026-06-30 was $204.1M. Net income was $5.0M. Revenue was up 5.1% from 2026-03-31 to 2026-06-30. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
MCHP currently screens at market cap $39.41B. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
Not investment advice. Open the MCHP and RGEN stock pages for the full models.
Not investment advice.